Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000
Go back to Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000| Exact Sciences Corp (NASDAQ: EXAS) | Delayed: 104.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.91 | 52 Week High | $22.80 | |||
| Open | $104.91 | 52 Week Low | $4.67 | |||
| Day High | $104.91 | P/E | N/A | |||
| Day Low | $104.91 | EPS | $-0.69 | |||
| Volume | 239,865 | |||||
